These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 28450105)
1. Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assay. Rosen O; Feldberg L; Dor E; Gura S; Zichel R Anal Biochem; 2017 Jul; 528():34-37. PubMed ID: 28450105 [TBL] [Abstract][Full Text] [Related]
2. Improved detection of botulinum type E by rational design of a new peptide substrate for endopeptidase-mass spectrometry assay. Rosen O; Feldberg L; Gura S; Zichel R Anal Biochem; 2014 Jul; 456():50-2. PubMed ID: 24721293 [TBL] [Abstract][Full Text] [Related]
3. A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay. Rosen O; Feldberg L; Gura S; Zichel R Anal Biochem; 2015 Mar; 473():7-10. PubMed ID: 25277815 [TBL] [Abstract][Full Text] [Related]
4. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification. Wang D; Baudys J; Ye Y; Rees JC; Barr JR; Pirkle JL; Kalb SR Anal Biochem; 2013 Jan; 432(2):115-23. PubMed ID: 23017875 [TBL] [Abstract][Full Text] [Related]
5. Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Bioorg Med Chem; 2015 Jul; 23(13):3667-73. PubMed ID: 25913863 [TBL] [Abstract][Full Text] [Related]
6. Improved detection of botulinum neurotoxin type A in stool by mass spectrometry. Wang D; Baudys J; Kalb SR; Barr JR Anal Biochem; 2011 May; 412(1):67-73. PubMed ID: 21276417 [TBL] [Abstract][Full Text] [Related]
7. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5. Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023 [TBL] [Abstract][Full Text] [Related]
9. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998 [TBL] [Abstract][Full Text] [Related]
10. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization. Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236 [TBL] [Abstract][Full Text] [Related]
11. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925 [TBL] [Abstract][Full Text] [Related]
12. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme. Ambrin G; Kumar R; Singh BR Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744 [TBL] [Abstract][Full Text] [Related]
13. Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry. Wang D; Baudys J; Hoyt KM; Barr JR; Kalb SR Anal Bioanal Chem; 2017 Aug; 409(20):4779-4786. PubMed ID: 28573317 [TBL] [Abstract][Full Text] [Related]
14. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. Hallis B; James BA; Shone CC J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885 [TBL] [Abstract][Full Text] [Related]
15. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A. Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358 [TBL] [Abstract][Full Text] [Related]
17. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro. Ekong TAN; Feavers IM; Sesardic D Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins. Sharma SK; Singh BR Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048 [TBL] [Abstract][Full Text] [Related]
19. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics. Moura H; Terilli RR; Woolfitt AR; Gallegos-Candela M; McWilliams LG; Solano MI; Pirkle JL; Barr JR FEMS Immunol Med Microbiol; 2011 Apr; 61(3):288-300. PubMed ID: 21205003 [TBL] [Abstract][Full Text] [Related]
20. A graphene oxide based fluorescence resonance energy transfer (FRET) biosensor for ultrasensitive detection of botulinum neurotoxin A (BoNT/A) enzymatic activity. Shi J; Guo J; Bai G; Chan C; Liu X; Ye W; Hao J; Chen S; Yang M Biosens Bioelectron; 2015 Mar; 65():238-44. PubMed ID: 25461164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]